Application of Genetically Altered Models as Replacement for the Lifetime Mouse Bioassay in Pharmaceutical Development

Author： Alden Carl Smith Peter Morton Dan

ISSN： 0192-6233

Source： Toxicologic Pathology, Vol.30, Iss.1, 2002-01, pp. : 135-138

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Tg.AC Genetically Altered Mouse: Assay Working Group Overview of Available Data

By Eastin William C. Mennear John H. Tennant Ray W. Stoll Ray E. Branstetter Dan G. Bucher John R. McCullough Bruce Binder Robert L. Spalding Judson W. Mahler Joel F.

Toxicologic Pathology, Vol. 29, Iss. 5, 2001-09 ,pp. : 60-80

Ashgate Publishing Ltd

Access to resources Recommend Favorite

The Trp53 Hemizygous Mouse in Pharmaceutical Development: Points to Consider for Pathologists

By Floyd Eugenia Mann Peter Long Gerald Ochoa Ricardo

Toxicologic Pathology, Vol. 30, Iss. 1, 2002-01 ,pp. : 147-156

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Expectations for Transgenic Rodent Cancer Bioassay Models

By Ashby John

Toxicologic Pathology, Vol. 29, Iss. 5, 2001-09 ,pp. : 177-182

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Genetically Engineered Rodent Models of Mammary Gland Carcinogenesis: An Overview

By Blackshear Pamela E.

Toxicologic Pathology, Vol. 29, Iss. 1, 2001-01 ,pp. : 105-116

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Mouse Models of Human Familial Cancer Syndromes

By WARD JERROLD DEVOR-HENNEMAN DEBORAH

Toxicologic Pathology, Vol. 32, Iss. 1, 2004-03 ,pp. : 90-98

Ashgate Publishing Ltd

Access to resources Recommend Favorite